No New News
There’s no new news to report on Allergan’s (AGN) RESTASIS generic competition, so let’s focus on the numbers — and the upside.
Research Reports
Research reports are available with a Paid Subscription.
Upgrade This?
Shares of Apple (AAPL) rose $15 to $566 yesterday as the stock got upgraded to Buy at a brokerage firm. Here’s my take on shares of
That’s Not So Bad
Shares of Facebook (FB) lost their mojo after saying teens aren’t on so much. But FB’s numbers have never looked better.
Solid Demand
Indian IT Outsourcer Cognizant Tech. Solutions (CTSH) is experiencing solid demand for its services, but this is being reflected in the stock price.
Wait it Out
I think investors should wait to get into shares of Visa (V) as there’s not much upside to V’s Fair Value at the current price.
Big Bump in Valuation
This quarter I’m giving Baidu.com (BIDU) a big bump in its valuation. Now the stock has a lot of upside going into 2014.
Orbital Maneuver
Global satellite operator ViaSat (VSAT) was flying-high this year, and then last quarter’s results changed the stock’s direction. Here’s my outlook on VSAT now:
Big Buybacks
Express Scripts (ESRX) isn’t growing sales, but profits keep climbing due to management’s big buyback of ESRX shares.
Still a Bright Future Ahead
I bought Celgene (CELG) last year for $69. Now after it’s more than doubled there is still a bright future ahead — especially in 2015.
Such a Sound Investment
GNC (GNC) is such a sound investment. And now the shares are on sale too. I see solid returns in 2014.
Beyond the Hype
I will purchase red-hot Vipshop (VIPS) for the Growth Stock Portfolio and Aggressive Growth Portfolio today. There’s profits beyond the hype.
Who Wants a Coach Bag?
Who wants a Coach (COH) handbag when you can have Michael Kors? Who wants COH stock when you can have KORS?